About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Foxo1tm1.1Rdp
targeted mutation 1.1, Ronald DePinho
MGI:3698868
Summary 8 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Foxo1tm1.1Rdp/Foxo1tm1.1Rdp involves: 129S1/Sv * FVB/N MGI:3706811
cn2
Foxo1tm1Rdp/Foxo1tm1.1Rdp
Igh-Jtm1Cgn/Ightm4Cgn
Tg(Cr2-cre)3Cgn/0
involves: 129P2/OlaHsd * 129S1/Sv MGI:4430557
cn3
Foxo1tm1.1Rdp/Foxo1+
Igh-Jtm1Cgn/Ightm4Cgn
Tg(Cr2-cre)3Cgn/0
involves: 129P2/OlaHsd * 129S1/Sv MGI:4430558
cn4
Adipoqtm1Ish/Adipoqtm1Ish
Foxo1tm1Rdp/Foxo1tm1.1Rdp
Tg(Col1a1-cre)1Kry/0
involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6J * FVB/N MGI:5520079
cn5
Foxo1tm1Rdp/Foxo1tm1.1Rdp
Tg(Col1a1-cre)1Kry/0
involves: 129S1/Sv * FVB MGI:5520078
cn6
Foxo1tm1Rdp/Foxo1tm1.1Rdp
Foxo3tm1Rdp/Foxo3tm1.1Rdp
Ptentm1Hwu/Ptentm1Hwu
Tg(CYP19A1-cre)1Jri/0
involves: 129S4/SvJae * 129S6/SvEvTac MGI:5784501
cn7
Foxo1tm1Rdp/Foxo1tm1.1Rdp
Foxo3tm1Rdp/Foxo3tm1.1Rdp
Tg(CYP19A1-cre)1Jri/0
involves: 129S6/SvEvTac MGI:5784494
cn8
Foxo1tm1Rdp/Foxo1tm1.1Rdp
Foxo3tm1Rdp/Foxo3tm1.1Rdp
Amhr2tm3(cre)Bhr/Amhr2+
involves: 129S6/SvEvTac * 129S7/SvEvBrd MGI:5784489


Genotype
MGI:3706811
hm1
Allelic
Composition
Foxo1tm1.1Rdp/Foxo1tm1.1Rdp
Genetic
Background
involves: 129S1/Sv * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Foxo1tm1.1Rdp mutation (0 available); any Foxo1 mutation (31 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging




Genotype
MGI:4430557
cn2
Allelic
Composition
Foxo1tm1Rdp/Foxo1tm1.1Rdp
Igh-Jtm1Cgn/Ightm4Cgn
Tg(Cr2-cre)3Cgn/0
Genetic
Background
involves: 129P2/OlaHsd * 129S1/Sv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Foxo1tm1.1Rdp mutation (0 available); any Foxo1 mutation (31 available)
Foxo1tm1Rdp mutation (2 available); any Foxo1 mutation (31 available)
Igh-Jtm1Cgn mutation (3 available); any Igh-J mutation (13 available)
Ightm4Cgn mutation (0 available); any Igh mutation (43 available)
Tg(Cr2-cre)3Cgn mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• mice exhibit an accumulation of IgM negative B cells compared to in Igh-Jtm1Cgn/Ightm4Cgn Tg(Cr2-cre)3Cgn mice
• mice exhibit an efficient rescue of BCR negative B cells compared with Igh-Jtm1Cgn/Ightm4Cgn Tg(Cr2-cre)3Cgn mice
• however, follicle B cells are rescued compared to in Igh-Jtm1Cgn/Ightm4Cgn Tg(Cr2-cre)3Cgn mice

hematopoietic system
• mice exhibit an accumulation of IgM negative B cells compared to in Igh-Jtm1Cgn/Ightm4Cgn Tg(Cr2-cre)3Cgn mice
• mice exhibit an efficient rescue of BCR negative B cells compared with Igh-Jtm1Cgn/Ightm4Cgn Tg(Cr2-cre)3Cgn mice
• however, follicle B cells are rescued compared to in Igh-Jtm1Cgn/Ightm4Cgn Tg(Cr2-cre)3Cgn mice




Genotype
MGI:4430558
cn3
Allelic
Composition
Foxo1tm1.1Rdp/Foxo1+
Igh-Jtm1Cgn/Ightm4Cgn
Tg(Cr2-cre)3Cgn/0
Genetic
Background
involves: 129P2/OlaHsd * 129S1/Sv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Foxo1tm1.1Rdp mutation (0 available); any Foxo1 mutation (31 available)
Igh-Jtm1Cgn mutation (3 available); any Igh-J mutation (13 available)
Ightm4Cgn mutation (0 available); any Igh mutation (43 available)
Tg(Cr2-cre)3Cgn mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• mice exhibit a limited rescue of IgM negative B cells compared to in Igh-Jtm1Cgn/Ightm4Cgn Tg(Cr2-cre)3Cgn mice

hematopoietic system
• mice exhibit a limited rescue of IgM negative B cells compared to in Igh-Jtm1Cgn/Ightm4Cgn Tg(Cr2-cre)3Cgn mice




Genotype
MGI:5520079
cn4
Allelic
Composition
Adipoqtm1Ish/Adipoqtm1Ish
Foxo1tm1Rdp/Foxo1tm1.1Rdp
Tg(Col1a1-cre)1Kry/0
Genetic
Background
involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6J * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Adipoqtm1Ish mutation (0 available); any Adipoq mutation (40 available)
Foxo1tm1.1Rdp mutation (0 available); any Foxo1 mutation (31 available)
Foxo1tm1Rdp mutation (2 available); any Foxo1 mutation (31 available)
Tg(Col1a1-cre)1Kry mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
N
• mice exhibit normal body weight

homeostasis/metabolism
N
• mice exhibit normal osteocalcin serum levels

skeleton
N
• mice exhibit normal bone mass and osteoblast numbers




Genotype
MGI:5520078
cn5
Allelic
Composition
Foxo1tm1Rdp/Foxo1tm1.1Rdp
Tg(Col1a1-cre)1Kry/0
Genetic
Background
involves: 129S1/Sv * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Foxo1tm1.1Rdp mutation (0 available); any Foxo1 mutation (31 available)
Foxo1tm1Rdp mutation (2 available); any Foxo1 mutation (31 available)
Tg(Col1a1-cre)1Kry mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
N
• mice exhibit normal osteocalcin serum levels




Genotype
MGI:5784501
cn6
Allelic
Composition
Foxo1tm1Rdp/Foxo1tm1.1Rdp
Foxo3tm1Rdp/Foxo3tm1.1Rdp
Ptentm1Hwu/Ptentm1Hwu
Tg(CYP19A1-cre)1Jri/0
Genetic
Background
involves: 129S4/SvJae * 129S6/SvEvTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Foxo1tm1.1Rdp mutation (0 available); any Foxo1 mutation (31 available)
Foxo1tm1Rdp mutation (2 available); any Foxo1 mutation (31 available)
Foxo3tm1.1Rdp mutation (1 available); any Foxo3 mutation (48 available)
Foxo3tm1Rdp mutation (1 available); any Foxo3 mutation (48 available)
Ptentm1Hwu mutation (16 available); any Pten mutation (81 available)
Tg(CYP19A1-cre)1Jri mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• 60% incidence of granulosa cell tumor occurrence, with early tumor development
• granulosa cell tumors are either solid and surrounded by a thin layer of ovarian tissue containing a few growing follicles or are larger and contain tubular-like structures of different sizes and shapes surrounded by a basal lamina of collagen IV
• mice injected with superovulatory levels of equine gonadotropin and human gonadotropin at 6 weeks of age develop large granulosa cell tumors early

homeostasis/metabolism
• tumor bearing mice exhibit increased levels of serum inhibin A and inhibin B
• serum follicle stimulating hormone levels are below the level of detection in tumor bearing mice
• serum luteinizing hormone levels are below the level of detection in tumor bearing mice

neoplasm
• 60% incidence of granulosa cell tumor occurrence, with early tumor development
• granulosa cell tumors are either solid and surrounded by a thin layer of ovarian tissue containing a few growing follicles or are larger and contain tubular-like structures of different sizes and shapes surrounded by a basal lamina of collagen IV
• mice injected with superovulatory levels of equine gonadotropin and human gonadotropin at 6 weeks of age develop large granulosa cell tumors early

reproductive system
• 60% incidence of granulosa cell tumor occurrence, with early tumor development
• granulosa cell tumors are either solid and surrounded by a thin layer of ovarian tissue containing a few growing follicles or are larger and contain tubular-like structures of different sizes and shapes surrounded by a basal lamina of collagen IV
• mice injected with superovulatory levels of equine gonadotropin and human gonadotropin at 6 weeks of age develop large granulosa cell tumors early




Genotype
MGI:5784494
cn7
Allelic
Composition
Foxo1tm1Rdp/Foxo1tm1.1Rdp
Foxo3tm1Rdp/Foxo3tm1.1Rdp
Tg(CYP19A1-cre)1Jri/0
Genetic
Background
involves: 129S6/SvEvTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Foxo1tm1.1Rdp mutation (0 available); any Foxo1 mutation (31 available)
Foxo1tm1Rdp mutation (2 available); any Foxo1 mutation (31 available)
Foxo3tm1.1Rdp mutation (1 available); any Foxo3 mutation (48 available)
Foxo3tm1Rdp mutation (1 available); any Foxo3 mutation (48 available)
Tg(CYP19A1-cre)1Jri mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• 1.5 month old mice injected with superovulatory levels of equine gonadotropin and human gonadotropin exhibit ovaries with many abnormal, degenerating follicles in which oocytes are shrunken or absent
• in some ovarian follicles of mice injected with superovulatory levels of equine gonadotropin and human gonadotropin, granulosa cells are abnormally displaced and growing on one side
• about 20% of mice develop granulosa cell tumors by 6-8 months of age
• most tumors from 6-11 months of age are unilateral and solid with regions of trabecular- and gyriform-like structures
• some tumors contain cystic or hemorrhagic follicle-like structures devoid of oocytes and/or regions of necrosis
• 65% of 1.5 month old mice injected with superovulatory levels of equine gonadotropin and human gonadotropin develop granulosa cell tumors or cysts

homeostasis/metabolism
• tumor bearing mice exhibit increased levels of serum inhibin A and inhibin B
• serum levels of estradiol are elevated in tumor bearing mice
• serum follicle stimulating hormone levels are below the level of detection in tumor bearing mice
• serum luteinizing hormone levels are below the level of detection in tumor bearing mice

neoplasm
• about 20% of mice develop granulosa cell tumors by 6-8 months of age
• most tumors from 6-11 months of age are unilateral and solid with regions of trabecular- and gyriform-like structures
• some tumors contain cystic or hemorrhagic follicle-like structures devoid of oocytes and/or regions of necrosis
• 65% of 1.5 month old mice injected with superovulatory levels of equine gonadotropin and human gonadotropin develop granulosa cell tumors or cysts

reproductive system
• 1.5 month old mice injected with superovulatory levels of equine gonadotropin and human gonadotropin exhibit ovaries with many abnormal, degenerating follicles in which oocytes are shrunken or absent
• in some ovarian follicles of mice injected with superovulatory levels of equine gonadotropin and human gonadotropin, granulosa cells are abnormally displaced and growing on one side
• about 20% of mice develop granulosa cell tumors by 6-8 months of age
• most tumors from 6-11 months of age are unilateral and solid with regions of trabecular- and gyriform-like structures
• some tumors contain cystic or hemorrhagic follicle-like structures devoid of oocytes and/or regions of necrosis
• 65% of 1.5 month old mice injected with superovulatory levels of equine gonadotropin and human gonadotropin develop granulosa cell tumors or cysts

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
ovarian cancer DOID:2394 OMIM:167000
OMIM:607893
J:232961




Genotype
MGI:5784489
cn8
Allelic
Composition
Foxo1tm1Rdp/Foxo1tm1.1Rdp
Foxo3tm1Rdp/Foxo3tm1.1Rdp
Amhr2tm3(cre)Bhr/Amhr2+
Genetic
Background
involves: 129S6/SvEvTac * 129S7/SvEvBrd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Amhr2tm3(cre)Bhr mutation (1 available); any Amhr2 mutation (27 available)
Foxo1tm1.1Rdp mutation (0 available); any Foxo1 mutation (31 available)
Foxo1tm1Rdp mutation (2 available); any Foxo1 mutation (31 available)
Foxo3tm1.1Rdp mutation (1 available); any Foxo3 mutation (48 available)
Foxo3tm1Rdp mutation (1 available); any Foxo3 mutation (48 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• ovaries of 3-4 month old mice contain many small abnormal follicles in which fragmented oocytes or only remnants of the zona pellucida are evident
• some follicles in 3-4 month old mice assume the appearance of testicular-like structures
• ovaries of 3-4 month old mice typically contain large cyst-like structures, some of which are hemorrhagic
• about 20% of mice develop granulosa cell tumors by 6-8 months of age
• most tumors from 6-11 months of age are unilateral and solid with regions of trabecular- and gyriform-like structures
• some tumors contain cystic or hemorrhagic follicle-like structures devoid of oocytes and/or regions of necrosis

homeostasis/metabolism
• tumor bearing mice exhibit increased levels of serum inhibin A and inhibin B
• serum levels of estradiol are elevated in tumor bearing mice
• serum follicle stimulating hormone levels are below the level of detection in tumor bearing mice
• serum luteinizing hormone levels are below the level of detection in tumor bearing mice

neoplasm
• about 20% of mice develop granulosa cell tumors by 6-8 months of age
• most tumors from 6-11 months of age are unilateral and solid with regions of trabecular- and gyriform-like structures
• some tumors contain cystic or hemorrhagic follicle-like structures devoid of oocytes and/or regions of necrosis

reproductive system
• ovaries of 3-4 month old mice contain many small abnormal follicles in which fragmented oocytes or only remnants of the zona pellucida are evident
• some follicles in 3-4 month old mice assume the appearance of testicular-like structures
• ovaries of 3-4 month old mice typically contain large cyst-like structures, some of which are hemorrhagic
• about 20% of mice develop granulosa cell tumors by 6-8 months of age
• most tumors from 6-11 months of age are unilateral and solid with regions of trabecular- and gyriform-like structures
• some tumors contain cystic or hemorrhagic follicle-like structures devoid of oocytes and/or regions of necrosis

growth/size/body
• ovaries of 3-4 month old mice typically contain large cyst-like structures, some of which are hemorrhagic

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
ovarian cancer DOID:2394 OMIM:167000
OMIM:607893
J:232961





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory